rs121917894
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000536.4(RAG2):c.686G>T(p.Arg229Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R229W) has been classified as Pathogenic.
Frequency
Consequence
NM_000536.4 missense
Scores
Clinical Significance
Conservation
Publications
- Omenn syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- recombinase activating gene 2 deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positiveInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00000658  AC: 1AN: 152028Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000796  AC: 2AN: 251160 AF XY:  0.0000147   show subpopulations 
GnomAD4 exome  AF:  0.0000157  AC: 23AN: 1461722Hom.:  0  Cov.: 31 AF XY:  0.0000193  AC XY: 14AN XY: 727182 show subpopulations 
Age Distribution
GnomAD4 genome  0.00000658  AC: 1AN: 152028Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74232 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas    Pathogenic:1 
This variant is present in population databases (rs121917894, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 229 of the RAG2 protein (p.Arg229Leu). This variant has not been reported in the literature in individuals affected with RAG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1483301). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RAG2 protein function. This variant disrupts the p.Arg229 amino acid residue in RAG2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11133745, 15025726, 16960852, 28747913). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at